Several recent research works can support the prior finding and show that APIs in MSNs sustain their chemical structure, unaffected by covalent bonding during adsorption, storage, or release. Porras et al. observed consistent FTIR peaks for drug-MSN systems (albendazole loaded into SBA-15), confirming the preservation of functional groups [ 50 ]. Ditzinger et al. attained the stabilization of haloperidol and carbamazepine in their amorphous forms through adsorption into mesoporous silica, sustaining their chemical integrity [ 51 ]. PXRD and DSC analyses confirmed that the drugs remained amorphous post-incorporation without recrystallization for at a minimum three months. Particularly, the absence of new PXRD peaks and DSC melting endotherms during this period signals there is no chemical degradation or alteration of the chemical structure [ 51 ]. Minecka et al. demonstrated that while aripiprazole transforms from crystalline to amorphous form upon adsorption into mesoporous silica, the chemical structure of the API remains unchanged [ 52 ]. To track the molecular state of the drug during and after amorphization, calorimetric, X-ray diffraction, and dielectric methods were carried out by the researchers to provide proof. The findings recommend that the steric hindrance impact averts recrystallization, consequently preserving chemical structures as amorphous APIs revert to the original form [ 52 ]. Knapik-Kowalczuk et al. found that celecoxib in Syloid 244FP exhibits stable FTIR and NMR signals and intact molecular dynamics after amorphization, showing stabilization via physical interactions (steric hindrance and surface interactions without extra bond formation) [ 53 ]. Richter et al. converted itraconazole to an amorphous form in the presence of mesoporous silica, without altering its chemical structure, by the twin-screw extrusion method, as confirmed by consistent thermal and diffraction analyses [ 54 ]. Furthermore, Antonino et al. highlighted the transition of naproxen and ibuprofen from crystalline to amorphous when they were adsorbed into mesoporous silica (Syloid 72FP) [ 55 ]. This change is purely physical, with no chemical alterations to the drug molecules. Approaches such as differential scanning calorimetry (DSC), X-ray diffraction (XRPD), and solid-state NMR verify that the APIs' chemical structure of the APIs remains intact throughout and after amorphization. Drug adsorption onto the silica surface creates a stabilized amorphous state that resists recrystallization without changing the chemical bonds of the APIs. This stabilization stems from physical confinement and interactions such as hydrogen bonding or van der Waals forces with the silica, without any chemical reactions or degradation [ 55 ]. In summary, MSNs accomplish API amorphization and stabilization through steric confinement and non-covalent adsorption, thereby preserving chemical structures, as verified by consistent data obtained by researchers.
Monodisperse Silica Spheres: Size Control, Synthesis and Applications
What Is the Common Name for Silicon Dioxide? Silica, Quartz and Other Names
Silica Mesh Size Chart: Mesh to Micron Conversion and How to Choose
Silica HS Code: Correct Customs Classification for Silica, Quartz and Silica Gel
Silica for Thermal Insulation: Aerogel, Fumed Silica and Microporous Materials Compared
104. Vialpando M., Backhuijs F., Martens J.A., Van Den Mooter G. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen. Eur. J. Pharm. Biopharm. 2012;81:190-198. doi: 10.1016/j.ejpb.2012.01.012. [ DOI ] [ PubMed ] [ Google Scholar ]
Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare
What is silica (SiO₂)?
silicon dioxide manufacturer
MSNs are also appropriate for pulmonary drug delivery. Inhalation is an attractive route of administration since the application is non-invasive and patient-friendly [ 18 ]. However, the rapid mucociliary clearance and the mucus hurdle complicate the intake of the API and are obstacles to be overcome [ 18, 25 ]. The mesoporous drug delivery systems may be really helpful in the treatment of lung diseases, as they can passively accumulate in the alveoli [ 25, 56, 72 ]. The passive accumulation is due to their small size, while the sizable surface area, high vascularity, and vascular permeability of the lungs enhance the process [ 56 ]. Furthermore, targeted treatment of tumors or inflamed cells can also be implemented with the functionalization of their surface [ 56, 72 ]. MSNs are typically delivered to the lungs in powder form with dry powder inhalers or suspended in liquid droplets with a nebulizer [ 56 ].
What is the difference between fumed silica and precipitated silica?
silica SDS
What drives silica raw material prices?
cristobalite
Cite this article: Silica Raw Materials News. "What Is Modified Silica? Surface Modification Methods and Performance Benefits
." Published 2026-11-20 01:07:39. /news/article.html Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.